ImmunologybioRxivPreprint
Listeria monocytogenes personalized cancer vaccines drive therapeutic immune responses to cancer derived neoantigens
B. Coder, O. Pryshchep, D. Kelkar…·M. Princiotta
This study demonstrates that ADXS-NEO, a personalized Listeria monocytogenes vaccine, effectively targets tumor-specific mutations and controls tumor growth in mice by inducing neoantigen-specific T cell responses.
DOI 10.1101/2020.05.11.088930